ArticleFrontiers in nutrition2025
Global burden, trends, and inequalities of gastric cancer attributable to high-sodium diets: a 30-year analysis and projections based on the global burden of disease 2021 study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biguanide‑modified ursolic acid as a multifunctional lipid‑mimetic carrier of DOX liposome for synergistic chemotherapy.Drug delivery and translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-sodium diet is a modifiable risk factor for gastric cancer, contributing substantially to its global burden. However, comprehensive evaluations of temporal, geographic, and sociodemographic patterns remain limited. Methods: Using Global Burden of Disease (GBD) 2021 data, we systematically assessed gastric cancer mortality and disability-adjusted life years (DALYs) attributable to high-sodium diets across 204 countries and territories from 1990 to 2021. Analytical approaches included joinpoint regression, age-period-cohort models, frontier efficiency, inequality metrics, and Bayesian projections to 2036. Results: Globally, age-standardized mortality and DALY rates declined significantly from 1990 to 2021 (EAPC for mortality: -2.26%; DALYs: -2.88%). The highest burden was observed in East Asia, with China and Mongolia being most affected. Disparities across sex, region, and sociodemographic index (SDI) persisted, with middle and high-middle SDI countries exhibiting peak age-standardized rates. Reductions were most pronounced in high SDI and high-income Asia-Pacific regions. Inequality, while reduced in absolute terms, remained evident. Projections indicate continued declines, but persistent regional differences. Conclusions: Despite global progress in reducing age-standardized rates, substantial absolute and relative disparities in gastric cancer burden attributable to high-sodium diets persist, especially in transitioning economies. Targeted policies combining sodium reduction, education, regulation, and improved healthcare access are vital to accelerate progress and achieve more equitable health gains worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.